RELATED PARTY TRANSACTIONS (Details) (USD $)	36 Months Ended					12 Months Ended					3 Months Ended	36 Months Ended		12 Months Ended					1 Months Ended	36 Months Ended					12 Months Ended					1 Months Ended			36 Months Ended		12 Months Ended
	Dec. 31, 2012 Employees [Member] Stock Option [Member]	Dec. 31, 2012 Employees [Member] Stock Option [Member] Minimum [Member]		Dec. 31, 2012 Employees [Member] Stock Option [Member] Maximum [Member]		Dec. 31, 2013 Employees [Member] Stock Option [Member]	Dec. 31, 2013 Employees [Member] Stock Option [Member] Minimum [Member]		Dec. 31, 2013 Employees [Member] Stock Option [Member] Maximum [Member]		Jun. 30, 2011 Employees and Officers [Member]	Dec. 31, 2012 Employees and Officers [Member] Stock Option [Member]		Dec. 31, 2013 Employees and Officers [Member] Stock Option [Member]	Dec. 31, 2013 Employees and Officers [Member] Stock Option [Member] Minimum [Member]		Dec. 31, 2013 Employees and Officers [Member] Stock Option [Member] Maximum [Member]		Feb. 29, 2012 Directors [Member]	Dec. 31, 2012 Directors [Member] Stock Option [Member]	Dec. 31, 2012 Directors [Member] Stock Option [Member] Minimum [Member]		Dec. 31, 2012 Directors [Member] Stock Option [Member] Maximum [Member]		Dec. 31, 2013 Directors [Member] Stock Option [Member]	Dec. 31, 2013 Directors [Member] Stock Option [Member] Minimum [Member]		Dec. 31, 2013 Directors [Member] Stock Option [Member] Maximum [Member]		Oct. 31, 2010 Chief Executive Officer and Chief Scientific Officer [Member]	Jul. 31, 2010 Chief Executive Officer and Chief Scientific Officer [Member]	Mar. 31, 2010 Chief Executive Officer and Chief Scientific Officer [Member]	Dec. 31, 2012 Chief Executive Officer and Chief Scientific Officer [Member] Stock Option [Member]		Dec. 31, 2013 Chief Executive Officer and Chief Scientific Officer [Member] Stock Option [Member]
Date of grant	Dec. 31, 2012											Sep. 30, 2011																					Jul. 31, 2010		Mar. 31, 2013
Date of grant start						Jan. 31, 2013								Jan. 31, 2013						Apr. 30, 2012					May 31, 2013
Date of grant end						Dec. 31, 2013								Jun. 30, 2013						Sep. 30, 2011					Oct. 31, 2013
Fair value of common stock on date of grant		$ 4.11	[1]	$ 4.24	[1]		$ 2.05	[1]	$ 5.19	[1]	$ 1.25	$ 0.9060	[2]		$ 4.11	[1]	$ 4.58	[1]	$ 6.00		$ 0.9060	[2]	$ 6.00	[3]		$ 2.04	[1]	$ 6.59	[1]	$ 2.756	$ 6.00	$ 3.00	$ 2.7560	[4]	$ 6.57	[1]
Exercise price of the options		$ 4.11		$ 4.24			$ 2.05		$ 5.19			$ 1.25			$ 4.11		$ 4.58				$ 1.25		$ 6.00			$ 2.04		$ 6.59					$ 5.00		$ 6.57
Expected life of the options (years)		5 years 8 months 26 days		6 years 1 month 10 days			6 years 1 month 2 days		6 years 1 month 10 days			5 years 7 months 24 days			5 years		6 years 1 month 10 days				5 years		5 years 7 months 24 days			5 years		5 years 3 months 22 days					3 years 3 months 29 days		5 years
Dividend yield	0.00%					0.00%						0.00%		0.00%						0.00%					0.00%								0.00%		0.00%
Expected volatility		42.44%		44.58%			40.73%		41.81%			53.90%			40.96%		41.05%				53.90%		62.46%			41.06%		41.53%					58.59%		47.09%
Risk-free interest rate		0.91%		0.99%			1.73%		1.97%			1.08%			1.03%		1.36%				0.89%		1.08%			0.73%		1.49%					1.03%		1.13%
Expected forfeiture per year (%)	10.00%					10.00%						10.00%		10.00%						0.00%					10.00%								0.00%		0.00%
Weighted-average fair value of the options (per unit)		1.7426		1.7842			0.878		2.18			0.3579			1.69		1.89				0.3579		3.3067			0.790		2.49					0.6744		2.70
Exercise Price of Warrants											$ 1.60

[1] The fair values of the Company's common stock were derived from the closing prices on the NASDAQ Capital Market as of the dates of grant.

[2] The fair value of the Company's common stock was derived implicitly from the Private Placement during April through June 2011 at $1.25 per Unit, wherein one Unit was comprised of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $1.60 per share.

[3] The fair value of the Company's common stock was derived implicitly from the public offering filed in February 2012 at $6.00 per share.

[4] The fair value of the Company's common stock was derived implicitly from the public offering filed in March 2010 at $3.00 per share and from the terms of an underwritten offering contemplated in July 2010 at $6.00 per Unit that was filed in October 2010, with $2.756 per share being allocated to common stock using an iterative approach in order for the combined fair value of the common stock and warrants to equal the amount of consideration to be received for the offering.